CN110117254A - 卡博替尼的制备方法 - Google Patents
卡博替尼的制备方法 Download PDFInfo
- Publication number
- CN110117254A CN110117254A CN201910538757.9A CN201910538757A CN110117254A CN 110117254 A CN110117254 A CN 110117254A CN 201910538757 A CN201910538757 A CN 201910538757A CN 110117254 A CN110117254 A CN 110117254A
- Authority
- CN
- China
- Prior art keywords
- preparation
- reaction
- quinoline
- dimethoxy
- card
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910538757.9A CN110117254B (zh) | 2019-06-20 | 2019-06-20 | 卡博替尼的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910538757.9A CN110117254B (zh) | 2019-06-20 | 2019-06-20 | 卡博替尼的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110117254A true CN110117254A (zh) | 2019-08-13 |
CN110117254B CN110117254B (zh) | 2022-05-13 |
Family
ID=67524415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910538757.9A Active CN110117254B (zh) | 2019-06-20 | 2019-06-20 | 卡博替尼的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110117254B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030140A2 (en) * | 2003-09-26 | 2005-04-07 | Exelixis, Inc. | C-met modulators and methods of use |
CN102227164A (zh) * | 2008-09-26 | 2011-10-26 | 葛兰素史密斯克莱有限责任公司 | 喹啉基氧基二苯基环丙烷二甲酰胺的制备 |
CN103664776A (zh) * | 2012-09-26 | 2014-03-26 | 正大天晴药业集团股份有限公司 | 一种酪氨酸激酶抑制剂及其中间体的制备方法 |
WO2015051149A1 (en) * | 2013-10-04 | 2015-04-09 | The Trustees Of Columbia University In The City Of New York | Sorafenib analogs and uses thereof |
CN105218445A (zh) * | 2015-08-25 | 2016-01-06 | 江苏中邦制药有限公司 | 一种络氨酸酶抑制剂Foretinib的制备方法 |
CN109232396A (zh) * | 2018-11-27 | 2019-01-18 | 聊城大学 | 酰胺吡啶类衍生物及其用途 |
-
2019
- 2019-06-20 CN CN201910538757.9A patent/CN110117254B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030140A2 (en) * | 2003-09-26 | 2005-04-07 | Exelixis, Inc. | C-met modulators and methods of use |
CN102227164A (zh) * | 2008-09-26 | 2011-10-26 | 葛兰素史密斯克莱有限责任公司 | 喹啉基氧基二苯基环丙烷二甲酰胺的制备 |
CN103664776A (zh) * | 2012-09-26 | 2014-03-26 | 正大天晴药业集团股份有限公司 | 一种酪氨酸激酶抑制剂及其中间体的制备方法 |
WO2015051149A1 (en) * | 2013-10-04 | 2015-04-09 | The Trustees Of Columbia University In The City Of New York | Sorafenib analogs and uses thereof |
CN105218445A (zh) * | 2015-08-25 | 2016-01-06 | 江苏中邦制药有限公司 | 一种络氨酸酶抑制剂Foretinib的制备方法 |
CN109232396A (zh) * | 2018-11-27 | 2019-01-18 | 聊城大学 | 酰胺吡啶类衍生物及其用途 |
Non-Patent Citations (5)
Title |
---|
XIN ZHAI等: "Syntheses and antiproliferative activities of novel diarylthiosemicarbazide derivatives", 《CHEMICAL RESEARCH IN CHINESE UNIVERSITIES》 * |
侯小娟等: "《有机化学》", 31 January 2019, 华中科技大学出版社 * |
张立娟: "(S)-苹果酸卡博替尼的合成工艺改进", 《中国医药工业杂志》 * |
李小清等: "喹啉-2-甲酸的合成", 《浙江化工》 * |
赵骏等: "《有机化学 供中药学 药学 制药技术 制药工程及相关专业使用 第2版》", 31 August 2018, 中国医药科技出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN110117254B (zh) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101570516B (zh) | 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的方法 | |
CN101863844B (zh) | 6,7-取代基-4-苯胺类喹唑啉的合成方法 | |
CN102030716B (zh) | 一种吉非替尼的制备方法 | |
CN107522743A (zh) | 一种半富马酸替诺福韦艾拉酚胺工业化连续生产方法 | |
CN101148439A (zh) | 一种吉非替尼的制备方法 | |
CN103664778B (zh) | 一种抗肿瘤治疗药物卡博替尼的合成方法 | |
CN104058954B (zh) | 一种在水相中制备酮亮氨酸钙的绿色工艺 | |
CN105218445B (zh) | 一种酪氨酸激酶抑制剂Foretinib的制备方法 | |
CN103012290B (zh) | 一种高纯度吉非替尼的制备方法 | |
CN108264482A (zh) | 一种卡博替尼的制备方法 | |
CN107118215B (zh) | 一种治疗乳腺癌药物瑞博西尼中间体的制备方法 | |
CN110117254A (zh) | 卡博替尼的制备方法 | |
CN106946880B (zh) | 一种制备瑞博西尼中间体的方法 | |
CN108503597A (zh) | 一种吉非替尼的高效制备方法 | |
CN104277028A (zh) | 吖啶-1,2,4-三唑-5-硫酮化合物及其制备方法和应用 | |
CN110183377A (zh) | 一种抗癌药物瑞戈非尼的合成方法 | |
CN102757350A (zh) | 厄罗替尼中间体3-氨基苯乙炔的制备方法 | |
CN109988108A (zh) | 一种卡博替尼的制备方法 | |
CN101805265B (zh) | 2-硝基-4-取代苯乙酸的合成方法 | |
CN103965104B (zh) | 一种酪氨酸激酶抑制剂及其中间体的制备方法 | |
CN106905234A (zh) | 一种合成来那替尼中间体3‑氰基‑4‑氯‑6‑氨基‑7‑乙氧基喹啉的方法 | |
CN110240563A (zh) | 一种卡博替尼的制备方法 | |
CN105175400A (zh) | 一种阿法替尼中间体的制备方法 | |
CN105250228B (zh) | 一种吉非替尼的片剂及其原料的制备方法 | |
CN102153518A (zh) | 吉非替尼的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 223800 No. 38 Yangzi Road, Eco-chemical Science and Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co., Ltd Applicant after: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Address before: 223800 No. 38 Yangzi Road, Eco-chemical Science and Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant before: JIANGSU JUNRUO PHARMACEUTICAL Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 223800 No. 38, Yangzi Road, ecological Chemical Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant after: Nantong Baikang biomedical Co.,Ltd. Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Address before: 223800 No. 38, Yangzi Road, ecological Chemical Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Applicant before: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |